The polio-eradication programme and issues of the end game

Area of Science:

• Virology
• Public Health
• Epidemiology

Background:

• Poliovirus causes paralytic poliomyelitis, a significant 20th-century public health concern.
• The gut is the primary infection site, with harmless virus replication.
• Two vaccines, oral polio vaccine (OPV) and inactivated polio vaccine (IPV), developed in the 1950s, prevent disease by inducing humoral immunity.

Purpose of the Study:

• To highlight the significance of understanding poliovirus pathogenesis and virology.
• To underscore the challenges in polio eradication, particularly those posed by the live oral polio vaccine (OPV).

Main Methods:

• This study is a review and analysis of existing literature on poliovirus.
• Focuses on the historical context, vaccine development, and eradication efforts.

Main Results:

• Vaccination has significantly reduced polio cases globally.
• The silent nature of poliovirus infection and the adaptability of OPV present eradication challenges.

Conclusions:

• Understanding poliovirus pathogenesis and virology is critical as the global eradication program nears its conclusion.
• The unique features of poliovirus and its vaccine necessitate continued research and strategic planning for complete eradication.